Portside Wealth Group’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-18,299
Closed -$107K 394
2023
Q4
$107K Sell
18,299
-35,051
-66% -$184K 0.02% 344
2023
Q3
$276K Sell
53,350
-6,208
-10% -$29.1K 0.05% 259
2023
Q2
$286K Buy
+59,558
New +$206K 0.05% 263

Other funds holding AUGX

Portside Wealth Group's AUGX Position: Q1 2024 in Review

Portside Wealth Group sold out of Augmedix, Inc. Common Stock (AUGX) in Q1 2024, closing a stake of 18,299 shares — an estimated $107K sold.

Portside Wealth Group first reported a position in AUGX in Q2 2023 and held it in 3 quarters. The position peaked at $286K in Q2 2023. 84 funds tracked by Wall St. Rank hold AUGX as of Q1 2024.

  • Portside Wealth Group reported no remaining Augmedix, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Portside Wealth Group sold 18,299 Augmedix, Inc. Common Stock shares in Q1 2024, an estimated $107K.
  • Portside Wealth Group first reported a position in Augmedix, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
  • Portside Wealth Group's Augmedix, Inc. Common Stock position peaked at $286K in Q2 2023.
  • 84 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q1 2024.

Based on Portside Wealth Group's 13F filing for Q1 2024, filed 17 Apr 2024.